SEC Form 4 · accession 0001645627-17-000092
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 10, 2017
Accepted (ET)
Jul 14, 2017 · 2:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2017 | P | 2,000 | $0.0284 | A | 21,541,349 | D | |
| Common Stock | Jul 10, 2017 | P | 2,000 | $0.0309 | A | 21,543,349 | D | |
| Common Stock | Jul 10, 2017 | P | 2,000 | $0.0294 | A | 21,545,349 | D | |
| Common Stock | Jul 11, 2017 | P | 2,000 | $0.0304 | A | 21,547,349 | D | |
| Common Stock | Jul 11, 2017 | P | 5,000 | $0.0304 | A | 21,552,349 | D | |
| Common Stock | Jul 11, 2017 | P | 5,000 | $0.0303 | A | 21,557,349 | D | |
| Common Stock | Jul 11, 2017 | P | 2,000 | $0.0304 | A | 21,559,349 | D | |
| Common Stock | Jul 12, 2017 | P | 2,000 | $0.0298 | A | 21,561,349 | D | |
| Common Stock | Jul 12, 2017 | P | 2,000 | $0.0297 | A | 21,563,349 | D | |
| Common Stock | Jul 12, 2017 | P | 2,000 | $0.03 | A | 21,565,349 | D | |
| Common Stock | Jul 12, 2017 | P | 5,000 | $0.0279 | A | 21,570,349 | D |
Table II — derivative securities
No Table II lines on this filing.